Literature DB >> 23664548

Blood pressure, proteinuria, and phosphate as risk factors for progressive kidney disease: a hypothesis.

Mario Cozzolino1, Giorgio Gentile, Sandro Mazzaferro, Diego Brancaccio, Piero Ruggenenti, Giuseppe Remuzzi.   

Abstract

Chronic kidney disease (CKD) affects approximately 500 million people worldwide and is increasingly common in both industrialized and emerging countries. Although the mechanisms underlying the inexorable progression of CKD are incompletely defined, recent discoveries may pave the way to a more comprehensive understanding of the pathophysiology of CKD progression and the development of new therapeutic strategies. In particular, there is accumulating evidence indicating a key role for the complex and yet incompletely understood system of divalent cation regulation, which includes phosphate metabolism and the recently discovered fibroblast growth factor 23 (FGF-23)/klotho system, which seems inextricably associated with vitamin D deficiency. The aim of this review is to discuss the links between high blood pressure, proteinuria, phosphate levels, and CKD progression and explore new therapeutic strategies to win the fight against CKD.
Copyright © 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; blood pressure; phosphate; proteinuria; vitamin D deficiency

Mesh:

Substances:

Year:  2013        PMID: 23664548     DOI: 10.1053/j.ajkd.2013.02.379

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  11 in total

1.  Discovery of endoplasmic reticulum calcium stabilizers to rescue ER-stressed podocytes in nephrotic syndrome.

Authors:  Sun-Ji Park; Yeawon Kim; Shyh-Ming Yang; Mark J Henderson; Wei Yang; Maria Lindahl; Fumihiko Urano; Ying Maggie Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

2.  Independent or synergistic relationship of proteinuria and glomerular filtration rate on patient and renal survival in patients with glomerulonephritis?

Authors:  Dominik G Haider; Salome Masghati; Georg Goliasch; Valentin Fuhrmann; Afschin Soleiman; Michael Wolzt; Andreas Baierl; Wilfred Druml; Walter H Hörl
Journal:  J Nephrol       Date:  2014-03-08       Impact factor: 3.902

3.  Effects of cardiorespiratory fitness on blood pressure trajectory with aging in a cohort of healthy men.

Authors:  Junxiu Liu; Xuemei Sui; Carl J Lavie; Haiming Zhou; Yong-Moon Mark Park; Bo Cai; Jihong Liu; Steven N Blair
Journal:  J Am Coll Cardiol       Date:  2014-09-23       Impact factor: 24.094

4.  Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort.

Authors:  Bradley A Warady; Alison G Abraham; George J Schwartz; Craig S Wong; Alvaro Muñoz; Aisha Betoko; Mark Mitsnefes; Frederick Kaskel; Larry A Greenbaum; Robert H Mak; Joseph Flynn; Marva M Moxey-Mims; Susan Furth
Journal:  Am J Kidney Dis       Date:  2015-03-19       Impact factor: 8.860

5.  Interaction between phosphorus and parathyroid hormone in non-dialysis CKD patients under nephrology care.

Authors:  Luca De Nicola; Giuseppe Conte; Paolo Chiodini; Pierluigi D'Angiò; Gerardo Donnarumma; Roberto Minutolo
Journal:  J Nephrol       Date:  2013-12-06       Impact factor: 3.902

6.  Plasma Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney Disease Patients.

Authors:  Dominik Steubl; Matthias Block; Victor Herbst; Wolfgang Andreas Nockher; Wolfgang Schlumberger; Robin Satanovskij; Susanne Angermann; Anna-Lena Hasenau; Lynne Stecher; Uwe Heemann; Lutz Renders; Jürgen Scherberich
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 7.  Use of Everolimus in Liver Transplantation: Recommendations From a Working Group.

Authors:  Paolo De Simone; Stefano Fagiuoli; Matteo Cescon; Luciano De Carlis; Giuseppe Tisone; Riccardo Volpes; Umberto Cillo
Journal:  Transplantation       Date:  2017-02       Impact factor: 4.939

Review 8.  Folic Acid and Homocysteine in Chronic Kidney Disease and Cardiovascular Disease Progression: Which Comes First?

Authors:  Giuseppe Cianciolo; Antonio De Pascalis; Luca Di Lullo; Claudio Ronco; Chiara Zannini; Gaetano La Manna
Journal:  Cardiorenal Med       Date:  2017-06-21       Impact factor: 2.041

9.  Small steps towards the potential of 'preventive' treatment of early phosphate loading in chronic kidney disease patients.

Authors:  Jordi Bover; Mario Cozzolino
Journal:  Clin Kidney J       Date:  2019-07-25

10.  Role of sodium/glucose cotransporter inhibition on a rat model of angiotensin II-dependent kidney damage.

Authors:  Humberto Reyes-Pardo; Rocío Bautista; Hilda Vargas-Robles; Amelia Rios; Daniel Sánchez; Bruno Escalante
Journal:  BMC Nephrol       Date:  2019-08-02       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.